Stay updated on Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.

Latest updates to the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page displays a new revision tag (v3.5.4) in place of the previous tag (v3.5.3), indicating a site version update rather than a change to study information.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page displays a new revision label v3.5.3, replacing the previous v3.5.2. This reflects a small update to the page version without changing its visible content.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. There are no visible changes to the study details or how users interact with the page.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3, reflecting the addition of v3.4.3 and removal of v3.4.2.SummaryDifference0.1%

- Check101 days agoChange DetectedAdded a Revision: v3.4.2 tag. Removed the government funding lapse notice and the prior Revision: v3.4.1 tag.SummaryDifference0.4%

Stay in the know with updates to Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.